Get all your news in one place.
100’s of premium titles.
One app.
Start reading
The Street
The Street
Business
Market Rebellion

Rebel's Edge -Analyzing Market News- $M, $DKS, $FULC, and Jalen Carter

Join Jon and Pete Najarian on today's episode of Rebel's Edge as they discuss stocks including Fulcrum Therapeutics getting FDA clearance for phase one of their sickle cell disease treatment trials, Dick's dealing with inventory shrink, Macy's reporting reduced sales, and Fabrinet riding the AI wave. Gain a deeper understanding of these stocks as Jon and Pete share their perspectives, potential growth prospects, and market predictions. They also talk about the unstoppable Jalen Carter, and University of Michigan's self-imposed suspension of Head Coach Jim Harbaugh. Stay on the cutting edge with Rebel's Edge.

Learn more about options trading with Jon and Pete at: https://marketrebellion.com

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.